Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has ...

If you are wondering whether Alcon's current share price reflects its true worth, this breakdown is designed to help you size ...

Alcon and Lensar are walking away from a proposed acquisition deal following pushback from the Federal Trade Commission (FTC) ...

Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More ...

The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye ...

One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...

Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.

ALC delivered fourth-quarter 2025 core earnings per share (EPS) of 78 cents, up 8.3% from the year-ago quarter’s figure. At ...

Lensar (LNSR) reached an agreement with Alcon (ALC) to terminate its planned sale. The parties are abandoning the deal as the ...

Give us an overview of Alcon and where it fits into India’s need for good quality eye care. Alcon has a legacy of more than ...